WinRho SDF

Rho (D) Immune Globulin (Human) For Injection


  • Composition
    Each vial for single use contain IgG anti Rho (D) 600 IU (120 mcg) 1500 IU (300 mcg) and 5000 IU (1000 mcg).

  • Indications
    Prevention of Rh immunization of Rho (D) negative women at risk of developing Rh antibodies.
    Prevention of alloimmunization in Rho (D) negative individuals transfused with Rho (D) positive red blood cells or blood components with red blood cells.
    Treatment of destructive thrombocytopenia of an immune etiology in situations where platelet counts must be increased to control bleeding.
    Childhood Chronic ITP
    Childhood Acute ITP
    Adult Chronic ITP
    ITP Secondary to HIV Infection

  • Contraindications
    When WinRho SDF™ Rho (D) Immune Globulin (Human) is used to prevent Rh alloimmunization it should not be administered to:
    1. Rho (D) positive individuals including babies;
    2. Rho (D) negative women who are Rh immunized as evidenced by standard manual Rh antibody screening tests.
    3. Individuals with a history of anaphylactic or other severe systemic reaction to immune globulins.
    Immune Thrombocytopenic Purpura
    When WinRho SDF™ is used to treat patients with ITP it should not be administered to:
    1. Rho (D) negative individuals
    2. Splenectomized individuals
    3. Individuals with known hypersensitivity to plasma products.

  • How Supplied
    WinRho SDF 120 mcg (600 UI) powder for injection
    WinRho SDF 300 mcg (1500 UI) powder for injection
    WinRho SDF 1000 mcg (5000 UI) powder for injection



(falta link a archivo)